Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

A cyanoguanidine-based prodrug identified as a clinical candidate by Leo scientists

Aug. 24, 2004

Protox Therapeutics retains CTBR for preclinical testing of PSA-PA1

Aug. 23, 2004

Viventia Biotech and Acceptys enter option agreement for anticancer antibodies

Aug. 23, 2004

Taxotere approved for early-stage breast cancer

Aug. 23, 2004

New phase I/II study of CG-7870 plus Taxotere for prostate cancer

Aug. 23, 2004

New EGFR inhibitors identified by Ariad scientists

Aug. 23, 2004

Fast track status for temsirolimus for first-line treatment of advanced RCC

Aug. 19, 2004

MediGene acquires anticancer drugs and technology of Munich Biotech

Aug. 19, 2004

Abbott presents new Bcl-targeting agents with potential in cancer chemotherapy

Aug. 18, 2004

FDA and Genentech issue warning on Avastin

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...